Annette Koerner, PhD, ERT, DABT
Basel Area, Switzerland
Global Advisor & NORD DTA liaison at Roche
Pharmaceuticals
Education
University of Hannover 1990 — 1999
PhD, Biology, General
American Board of Toxicology
Diplomate of the American Board of Toxicology, General Toxicology, DABT
Experience
Roche October 2012 - Present
Roche October 2012 - April 2014
Roche Pharmaceuticals August 2011 - October 2012
Roche Pharmaceuticals March 2003 - October 2012
Boehringer Ingelheim Pharmaceuticals May 1999 - May 2003
Boehringer Ingelheim Pharmaceuticals May 1999 - May 2003
Skills
Drug Development, Cross-functional Team..., EDC, Virology, Pharmacovigilance, In Vitro, Translational Research, Monoclonal Antibodies, IND, Pharmaceutical Industry, Biomarkers, Regulatory Affairs, Translational Medicine, Vaccines, Regulatory Submissions, Clinical Pharmacology, Cancer, Immunology, Clinical Development, Molecular Biology, Oncology, Clinical Trials, GCP, Toxicology, CTMS, Infectious Diseases, Assay Development, Pharmacology, Biotechnology, Therapeutic Areas, GLP, In Vivo, Drug Discovery, Lifesciences, Pharmacokinetics, Life Sciences, Medical Writing, Clinical Monitoring, Biochemistry, Bioanalysis, Protocol, CRO, Medical Affairs, Neuroscience, Biopharmaceuticals